Latest / Let's Talk Risk! Podcast
Deep Dive: The PFAS Substitution Risk Paradox in Medical Devices
FDA: There is no reason to restrict the continued use of fluoropolymers in medical devices.
What happens when pressure to eliminate a material creates greater risk for the patient?
This Deep Dive examines the growing regulatory tension around PFAS and medical-device fluoropolymers, and why evaluating substitution requires more than asking whether a material belongs to a broad chemical category.
Key highlights covered in the audio:
* Not all PFAS present the same risk. The discussion distinguishes small-molecule PFAS from large, biostable fluoropolymers such as PTFE and PVDF used in medical…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.